Harnessing the MYB-dependent TAL1 5’super-enhancer for targeted therapy in T-ALL

Overview of attention for article published in Molecular Cancer, January 2023

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (63rd percentile)
Above-average Attention Score compared to outputs of the same age and source (57th percentile)

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 1,127 followers.

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.